(C) Common Dreams
This story was originally published by Common Dreams and is unaltered.
. . . . . . . . . .



Bristol-Myers Squibb and Pfizer sue to block generic Eliquis [1]

['Jan Wolfe']

Date: 2017-04-07 21:43:28+00:00

Bristol-Myers Squibb Company and Pfizer Inc have asked a judge to uphold the validity of patents on their blockbuster blood thinner Eliquis and halt a planned generic version by Mylan Inc.

BMS and Pfizer, who jointly developed Eliquis, sued Mylan in federal court in Delaware on Wednesday, alleging the latter’s generic would infringe on one patent owned by BMS and another owned by both companies. They are also seeking a declaration that the two patents are valid.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2nnvTqS

[END]
---
[1] Url: https://www.reuters.com/article/bristol-myers-squibb-and-pfizer-sue-to-b/bristol-myers-squibb-and-pfizer-sue-to-block-generic-eliquis-idUSL1N1HF1WL

Published and (C) by Common Dreams
Content appears here under this condition or license: Creative Commons CC BY-NC-ND 3.0..

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/commondreams/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.